“…[1] More recently,R NA interference has emerged as an experimental tool to inhibit the expression of genes and gave birth to,r espectively,a ntisense oligonucleotides [2] and small interfering RNA( siRNA), [3] which are under intensive studies as high potential therapeutic agents. [7] In the case of oligonucleotides, the synthetic access to SILS is particularly problematic because of their complexity and relative instability.U pt o now,t he nucleobase hydrogen-isotope labelling is mainly achieved by multistep synthesis starting from precursors such as halogen, ketone,o ra ldehyde derivatives followed by, respectively,c atalytic dehalogenation using D 2 /T 2 gas [8] or reduction with labelled reagents [9] (NaBD 4 or LiAlT 4 for instance). [5] Indeed, tritiated analogues of drug candidates,are essential tools for investigating the in vivo fate of substances within absorption, distribution, metabolism and excretion (ADME) studies.…”